Get the Weekly Intelligence Brief — top committee picks every Sunday.
SW · NYSE · STOCK

Smurfit Westrock (SW) Stock Analysis

Consumer Cyclical Updated September 05, 2026
$45.80
52W $32.73 – $52.65
49/100
$23.74B
48.4
0.98
AI Committee Verdict
Watch
49/100
Conviction: Contested · 40% agreement · 5 analysts
+5.5%
-7.2%
0.76:1
Contested

Is SW Bullish or Bearish?

Mixed. Innellis AI committee rates Smurfit Westrock (SW) Watch with a composite score of 49/100 , based on 5 analysts with 40% agreement. Last updated September 05, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +11.08 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -8.92 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Growth Analyst remains cautious — revenue declining -29.4% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Price-to-book of 1.1x is a discount to asset value — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • News sentiment is positive (+0.17 across 6 articles, 14d) — News
Bear Case
  • P/E of 47.6 is expensive by classic value standards — Value
  • ROE of only 2.7% -- cheap may mean cheap for a reason — Value
  • Revenue declining -29.4% YoY -- this is not a growth story right now — Growth
  • EPS declining -21.4% YoY despite any revenue growth — Growth
  • 5 consecutive earnings misses -- execution concerns — Growth
  • RSI at 28 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of September 05, 2026
Overall Committee Score
49/100
Agreement
40%
Analysts
5
Conviction
Contested
Sector Rank
Top 90%
of 178 Consumer Cyclical peers
Value Analyst neutral
43 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 1.1x is a discount to asset value
− P/E of 47.6 is expensive by classic value standards
Growth Analyst bearish
35 / 100 · High confidence
Growth story is weak, decelerating, or inconsistent
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
− Revenue declining -29.4% YoY -- this is not a growth story right now
Technical Analyst bearish
38 / 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− RSI at 28 is in oversold territory (could mean either capitulation or a bounce setup)
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
63 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.17 across 6 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 3059.07)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 48.9 to 48.9.

Comparing 2026-09-04 to 2026-09-05 (1 day apart).

Technical Analysis

RSI (14)
28.4
Oversold
MACD Histogram
-0.573
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Support
$41.95
Resistance
$47.72
Bollinger %B
0.00
Inside Bands
Price vs Moving Averages
EMA 9
$46.88 Below
EMA 21
$47.44 Below
EMA 50
$46.52 Below
EMA 200
$43.80 Above

Fundamental Analysis

Valuation
58
Growth
20
Profitability
9
Financial Health
70
Cash Flow
70
Valuation
P/E Ratio 48.4×
P/B Ratio 1.37×
PEG Ratio 1.49
Dividend Yield 3.89%
52W High $52.65
52W Low $32.73
Quality & Growth
ROE 324.7%
ROA 131.8%
Gross Margin 1793.5%
Operating Margin 535.1%
Revenue Growth YoY
Debt / Equity 0.79
AI Fundamental Assessment
P/E ratio of 48.4 (rich relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 1.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 3.2%; Return on assets of 1.3%; Net margin of 1.6%; Gross margin of 17.9%; Current ratio of 1.45 (tight short-term liquidity); Debt-to-equity of 0.79; Free cash flow per share is positive (1.89); Most recent quarter missed estimates by 19.8%; 5 consecutive earnings misses; EPS growth accelerating (-2.9% -> +6.1% QoQ); Average YoY EPS growth of -40.7%; Analyst estimates falling over recent quarters
Get the Full SW Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime